CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −360 | $512.57 | $185K | 7,395 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −6,635 | $514.28 | $3.4M | 760 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −200 | $515.24 | $103K | 560 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −360 | $516.36 | $186K | 200 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −120 | $517.66 | $62K | 80 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −80 | $518.99 | $42K | 0 |
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −6,190 | 0 | ||
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −1,685 | 68,065 | ||
| 2025-12-22 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −14,625 | 126,375 | ||
| 2025-12-22 | SULLIVAN LOUIS W Director | Option exercise | +3,230 | $183.98 | $594K | 3,230 |
| 2025-12-22 | SULLIVAN LOUIS W Director | Option exercise | +2,720 | $229.81 | $625K | 5,950 |
| 2025-12-22 | SULLIVAN LOUIS W Director | Sale | −1,087 | $511.22 | $556K | 4,863 |
| 2025-12-22 | SULLIVAN LOUIS W Director | Sale | −4,863 | $512.34 | $2.5M | 0 |
| 2025-12-22 | SULLIVAN LOUIS W Director | Option exercise · Stock Options | −3,230 | 0 | ||
| 2025-12-22 | SULLIVAN LOUIS W Director | Option exercise · Stock Options | −2,720 | 1,840 | ||
| 2025-12-19 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +2,000 | $120.26 | $241K | 2,130 |
| 2025-12-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $505.45 | $253K | 1,630 |
| 2025-12-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $507.61 | $761K | 130 |
| 2025-12-19 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −2,000 | 0 | ||
| 2025-12-18 | Thompson Tommy G Director | Option exercise | +910 | $101.80 | $93K | 9,390 |
Page 166 of 171 · 3,408 trades